Chief Business Officer

Andrew’s ‘deal sheet’ includes partnerships with AstraZeneca, Ionis Pharmaceuticals, Alexion Pharmaceuticals, and Juvenile Diabetes Research Foundation. His degrees include an […]
Read More >